ArticleJournal of cellular and molecular medicine2018

Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.

Hailong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.